Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 51.90
-0.30 (-0.57%)
Jul 31, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 40.24 | 77.59 | 10.45 | 12.15 | -6.83 |
Depreciation & Amortization | 1.81 | 1.73 | 1.58 | 1.1 | 0.75 |
Stock-Based Compensation | 5.24 | 5.07 | 4.76 | 3.6 | 4.32 |
Other Adjustments | 6.03 | -16.32 | 1.77 | 1.94 | 3.12 |
Change in Receivables | -5.11 | -0.77 | 3.45 | 2.59 | -32.06 |
Changes in Inventories | 10.05 | -5.2 | -2.17 | -1.46 | -1.59 |
Changes in Accounts Payable | 3.57 | 5.64 | 5.66 | -10.43 | -2.54 |
Changes in Accrued Expenses | 0.06 | 7.4 | -10.93 | -0.85 | 5.44 |
Changes in Unearned Revenue | -1.97 | 2.31 | -1.23 | -1.23 | -2.56 |
Changes in Other Operating Activities | 2.16 | -3.08 | 0.91 | -0.34 | -0.08 |
Operating Cash Flow | 62.09 | 74.36 | 14.25 | 7.06 | -32.02 |
Operating Cash Flow Growth | -16.50% | 422.03% | 101.89% | - | - |
Capital Expenditures | -2.62 | -1.71 | -0.81 | -3.14 | -0.58 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.02 |
Purchases of Intangible Assets | -0.24 | -0.08 | -0.22 | -0.17 | -0.28 |
Purchases of Investments | - | - | - | - | -35 |
Proceeds from Sale of Investments | - | - | - | 94.95 | 41.02 |
Proceeds from Business Divestments | - | 0.78 | - | - | -1.6 |
Investing Cash Flow | -2.86 | -1.01 | -1.03 | 91.65 | 3.58 |
Long-Term Debt Issued | - | - | - | 73.88 | - |
Long-Term Debt Repaid | -22.04 | -15.6 | -59.31 | -123.55 | -23.21 |
Net Long-Term Debt Issued (Repaid) | -22.04 | -15.6 | -59.31 | -49.67 | -23.21 |
Issuance of Common Stock | 0.62 | 2.44 | 2.01 | 4.43 | 39.85 |
Net Common Stock Issued (Repurchased) | 0.62 | 2.44 | 2.01 | 4.43 | 39.85 |
Financing Cash Flow | -21.43 | -13.16 | -57.31 | -45.25 | 16.64 |
Foreign Exchange Rate Adjustments | -0.03 | 0.05 | -0.15 | 0.16 | 0.5 |
Net Cash Flow | 37.78 | 60.24 | -44.25 | 53.61 | -11.3 |
Free Cash Flow | 59.47 | 72.65 | 13.43 | 3.92 | -32.6 |
Free Cash Flow Growth | -18.14% | 440.89% | 242.83% | - | - |
FCF Margin | 25.59% | 34.84% | 8.52% | 2.65% | -22.01% |
Free Cash Flow Per Share | 4.35 | 5.24 | 1.11 | 0.33 | -2.79 |
Levered Free Cash Flow | 31.26 | 69.08 | -55.87 | -53.88 | -31.19 |
Unlevered Free Cash Flow | 58.28 | 85.86 | 12.18 | 2.26 | 0.05 |